AIM Vaccine Co., Ltd., a leading PRC vaccine company, announced today that its independently developed mRNA RSV (respiratory syncytial virus) vaccine has recently been submitted for clinical trials to the U.S. Food and Drug Administration (FDA).
AIM Vaccine submits mRNA RSV vaccine for FDA clinical trials
- Post author:admin
- Post published:February 10, 2025
- Post category:uncategorized